University of Illinois Patent applications |
Patent application number | Title | Published |
20130083161 | REAL-TIME VIDEO CODING USING GRAPHICS RENDERING CONTEXTS - A method for encoding video for streaming includes receiving a plurality of sequential image frames generated by a 3D graphics rendering engine. Graphics rendering contexts are obtained, including pixel depth map, rendering camera parameters, and camera motion from the 3D rendering engine. The method next entails selecting key frames among the plurality of sequential image frames, interpolating non-key frames via 3D image warping, and encoding all key frames and warping residues of non-key frames. The system is implementable on a server linked to a mobile user device for receiving the encoded frame data. The mobile user device is configured to decode the encoded frame data and display a corresponding image to a user of the mobile user device. | 04-04-2013 |
20110262398 | CARDIAC TREATMENT USING ANTI-FIBROTIC AGENTS - Disclosed herein are reagents and methods for detecting and treating age-related diastolic dysfunction in an animal or a human. | 10-27-2011 |
20090239231 | RNA From Cytology Samples To Diagnose Disease - The invention relates to methods and kits for detecting the likelihood that a subject has cancer, e.g., squamous cell carcinoma, by assaying the expression levels of tumor associated genes. More specifically, the expression levels of nucleic acids or proteins can be assayed in the tumor associated genes, e.g., beta-2 microgobulin (B2M) and cytochrome p450 1B1 (CYP1B1). The expression levels compared to standards can be indicative of the likelihood a subject has squamous cell carcinoma. For example, over-expression of B2M and under-expression of CYP1B1 can be indicative of the likelihood a subject has squamous cell carcinoma. Also, over-expression of B2M and over-expression of CYP1B1 can be indicative of the likelihood a subject has a precancerous squamous cell disorder. The expression levels of B2M and CYP1B1 can also be repeatedly assayed to monitor the progression of a squamous cell neoplasia. | 09-24-2009 |
20090175832 | Isolated Embryonic-Like Stem Cells Derived From Human Umbilical Cord Blood - The present invention is related generally to embryonic-like stem cells isolated from human umbilical cord blood, designated herein as cord blood-stem cells (CB-SC's), which display the characteristics of embryonic stem cells and hematopoietic cells. These cells have the capability of proliferation and are able to differentiate to multiple types of cells. In addition, the CB-SC display low immunogenicity and immune regulation. These cells are, therefore, suitable for use in stem cell-based therapies for the treatment of diseases such as Parkinson's disease, diabetes, spinal cord damage, multiple sclerosis, cardiovascular disease, stroke and birth defects, and for preventing, treating and/or reducing an autoimmune disease in a mammalian subject. | 07-09-2009 |